Deborah S. Kreiss

Biology The University of Tennessee, Knoxville, TN, United States 
Obsessive compulsive disorder
"Deborah Kreiss"
Mean distance: 16.35 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kreiss DS, Coffman CF, Fiacco NR, et al. (2013) Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder. Pharmacology, Biochemistry, and Behavior. 104: 119-24
Kreiss DS, Lucki I. (1997) Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Synapse (New York, N.Y.). 25: 107-16
Kreiss DS, Lucki I. (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. The Journal of Pharmacology and Experimental Therapeutics. 274: 866-76
Kirby LG, Kreiss DS, Singh A, et al. (1995) Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse (New York, N.Y.). 20: 99-105
Lucki I, Singh A, Kreiss DS. (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neuroscience and Biobehavioral Reviews. 18: 85-95
Kreiss DS, Lucki I. (1994) Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics. 269: 1268-79
Kreiss DS, Lucki I. (1994) Discriminative Stimulus Properties of the Serotonin Uptake Inhibitor Sertraline Experimental and Clinical Psychopharmacology. 2: 25-36
Kreiss DS, Wieland S, Lucki I. (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52: 295-301
Kreiss DS, Lucki I. (1992) Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology. 31: 1073-6
See more...